Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

PP2Cη Inhibitors

PP2Cη inhibitors are chemical compounds that specifically target the phosphatase activity of the enzyme PP2Cη (Protein Phosphatase 2Cη). PP2Cη belongs to the PP2C family of serine/threonine phosphatases, which are characterized by their requirement for magnesium or manganese ions as cofactors. These phosphatases play an essential role in various cellular processes, particularly in dephosphorylation events that regulate signal transduction pathways. PP2Cη, like other PP2C family members, is involved in maintaining the balance of phosphorylation states in proteins, which is critical for controlling cellular responses to environmental stimuli, including stress and growth factors. The selective inhibition of PP2Cη is of significant biochemical interest because this enzyme's activity is tightly linked to key regulatory processes, including cellular differentiation and proliferation.

The inhibitors of PP2Cη are designed to interfere with the catalytic domain of the enzyme, typically by blocking the interaction with its metal ion cofactors or by competing with its substrate-binding sites. Structurally, these inhibitors are diverse, and they often feature complex scaffolds that allow for high-affinity binding to the PP2Cη active site. By disrupting the normal function of PP2Cη, these compounds can modulate the phosphorylation state of downstream targets, affecting various biochemical pathways such as those related to stress responses, metabolic regulation, and cell cycle control. The study of PP2Cη inhibitors has led to deeper insights into the mechanistic roles of this enzyme in cellular physiology, offering valuable tools for probing the dynamic processes that underpin cellular regulation and signal transduction.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This chemical may cause hypomethylation of the PP2Cη gene promoter, potentially leading to a decrease in its transcriptional initiation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

By inhibiting histone deacetylase activity, this compound could lead to hyperacetylation of histones near the PP2Cη gene, resulting in transcriptional repression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

As a DNA methyltransferase inhibitor, 5-Aza-2′-Deoxycytidine could lead to the demethylation of the PP2Cη gene promoter, which may decrease gene transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

This HDAC inhibitor may promote the acetylation of histones at the PP2Cη gene locus, potentially reducing the initiation of transcription for this gene.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

By targeting mTOR signaling, this compound could decrease the translation of key regulators necessary for PP2Cη gene expression.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

This kinase inhibitor may disrupt the Ras/Raf/MEK/ERK pathway, potentially leading to a reduction in transcription factors that drive PP2Cη expression.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

By inhibiting cyclin-dependent kinases, flavopiridol could reduce the phosphorylation of transcriptional machinery, resulting in decreased PP2Cη gene transcription.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

This proteasome inhibitor could lead to the accumulation of misfolded proteins, triggering a cellular response that may include the downregulation of PP2Cη expression.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Thalidomide could downregulate PP2Cη expression by promoting the degradation of transcription factors specific to the PP2Cη gene through the ubiquitin-proteasome pathway.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$49.00
$367.00
$2030.00
18
(1)

This thalidomide analogue could decrease the transcription of PP2Cη by enhancing the degradation of specific transcription factors involved in its gene expression.